I was in the media bullpen with the team when the future arrived. The launch of Roferon-A, alpha interferon marked…
In an era where access to effective obesity care remains mired in controversy over medication costs and payer reluctance, a…
There’s a truth in health innovation: “Where data meets intent, change follows.” The latest Galen Growth report—FemTech 2.0: Doubling Down…
Researchers at the Icahn School of Medicine at Mount Sinai have developed a machine learning tool that can help doctors…
We have all seen the headlines. Government-funded research projects for cancer and other chronic and infectious diseases that, until a…
ntroduction Artificial Intelligence (AI) is rapidly reshaping public health — from enhancing disease surveillance and diagnostics to easing workforce burdens…
Cancer that is diagnosed at an early stage, before it has grown and spread through the body, is more likely…
Why the American healthcare sector should oppose plans for U.S. diplomatic withdrawal from Africa. Imagine it’s the mid-1990s and the…
“Branding is a matter of building trust and committing to a level of quality and service. It is an emotional…
*This story will be updated as more details become available* President Trump’s executive order could result in higher US medicines…
This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.
Read More